• Meropenem Trihydrate: Carbapenem Antibiotic in Resistance St

  2026-07-23

  Meropenem trihydrate empowers high-fidelity resistance profiling and mechanistic microbiology research. This article details advanced protocols, troubleshooting, and the metabolomics-driven innovations transforming how scientists investigate carbapenem-resistant pathogens.

• nor-Binaltorphimine dihydrochloride in Opioid Receptor Resea

  2026-07-23

  nor-Binaltorphimine dihydrochloride empowers precision dissection of κ-opioid receptor pathways, offering researchers a robust tool for pain modulation and neural circuit analysis. Recent breakthroughs leverage its selectivity to unravel complex brain-to-spinal pain mechanisms with reproducible, quantitative insights.

• TCAIM-Mediated OGDH Regulation: A New Layer in Mitochondrial

  2026-07-22

  Wang et al. (2025) reveal that the mitochondrial DNAJC co-chaperone TCAIM specifically binds and reduces the protein levels of the α-ketoglutarate dehydrogenase (OGDH) complex, thereby suppressing its activity and modulating cellular metabolism. This work identifies a novel post-translational regulatory mechanism with implications for mitochondrial proteostasis and metabolic control.

• DT-TRAP: Precision Target Recognition via Dose and Temperatu

  2026-07-22

  DT-TRAP introduces an optimized chemoproteomic workflow that combines rational dose selection with low-temperature incubation to enhance specificity in protein target identification. This innovation addresses longstanding challenges in chemoproteomics by minimizing nonspecific binding and reducing resource consumption, with significant implications for drug discovery and phosphoprotein analysis.

• Dihydroartemisinin: Advanced Protocols for mTOR & Malaria Re

  2026-07-21

  Dihydroartemisinin, a potent Artemisia plant extract, redefines cell signaling and antimalarial research through robust mTOR pathway inhibition and superior assay reliability. This guide delivers actionable workflows, troubleshooting strategies, and practical insights to maximize reproducibility when using APExBIO’s ultra-pure Dihydroartemisinin in advanced biomedical applications.

• Topotecan (SKF104864): Expanding Antitumor Frontiers in Canc

  2026-07-21

  Explore the molecular intricacies and translational potential of Topotecan (SKF104864) as a topoisomerase I inhibitor. This article delivers advanced insight into its mechanism, pediatric and glioma model utility, and unique assay optimization for modern cancer research.

• TiO2-Nanoparticle Sonodynamic Therapy Induces Ferroptosis to

  2026-07-20

  This study demonstrates that TiO2-nanoparticle–enhanced sonodynamic therapy (SDT) can effectively prevent posterior capsular opacification (PCO) through the induction of ferroptosis in human lens epithelial cells. By establishing precise ultrasound parameters and elucidating redox-driven mechanisms, the research provides a promising, biosafe strategy for addressing a major complication following cataract surgery.

• ARCA EGFP mRNA (5-moUTP): Maximizing Polyadenylated mRNA Per

  2026-07-20

  Explore how ARCA EGFP mRNA (5-moUTP) sets a new benchmark for polyadenylated mRNA in mammalian cell transfection. This article uniquely examines the interplay between mRNA structure, immunogenicity, and storage dynamics, offering advanced assay guidance for fluorescence-based experimentation.

• Comparative Antioxidant and α-Glucosidase Profiles in Taihan

  2026-07-19

  This study systematically compares wild and cultivated Taihangia rupestris leaves, revealing that foothill-cultivated plants possess enhanced flavonoid and phenolic content as well as superior antioxidant and α-glucosidase inhibitory activities. The findings support sustainable cultivation strategies for producing bioactive compounds relevant to antidiabetic research.

• CCR7/DUSP1 Axis in iCAF Regulates HNSCC Growth via TGF-β1

  2026-07-18

  This study delineates how the CCR7/DUSP1 signaling axis in inflammatory cancer-associated fibroblasts (iCAF) orchestrates tumor growth in head and neck squamous cell carcinoma (HNSCC) through modulation of TGF-β1 secretion. The findings provide mechanistic clarity on tumor–stroma interactions and highlight experimental strategies for dissecting cell proliferation dynamics in the tumor microenvironment.

• Sumatriptan Succinate: Anti-Inflammatory Actions Beyond Migr

  2026-07-17

  The referenced systematic review critically assesses emerging evidence for sumatriptan’s anti-inflammatory activity, extending its recognized role as a 5-HT1B/1D receptor agonist in migraine therapy. This work highlights mechanistic insights, including cytokine modulation and neurovascular effects, that may reposition sumatriptan as a research tool in inflammation beyond headache models.

• PLGA Nano-Adjuvant Enhances Chick Mucosal and Systemic Immun

  2026-07-17

  A novel PLGA-based nano-adjuvant (PEI-LSP-RA-PLGA) significantly boosts both mucosal and systemic immune responses in chicks vaccinated against H9N2 avian influenza. This approach offers targeted intestinal delivery and sustained antigen release, addressing major limitations of traditional adjuvants and informing future poultry vaccine strategies.

• ABT-199 (Venetoclax): Redefining Apoptosis Pathways in Trans

  2026-07-16

  Explore how ABT-199 (Venetoclax), a highly selective Bcl-2 inhibitor, is transforming the mechanistic and strategic landscape of apoptosis research. Grounded in cutting-edge insights into mitochondrial signaling and RNA Pol II-mediated cell death, this article bridges foundational biology, experimental rigor, and translational innovation for researchers tackling hematologic malignancies.

• Solanesol: Research Handling and Workflow Parameters

  2026-07-16

  Solanesol is a high-purity polyisoprenoid alcohol designed for research applications involving hydrophobic compound handling, such as apoptosis research, DNA damage and repair studies, and metabolic enzyme assays. It is not suitable for aqueous or ethanol-based systems, diagnostic, or clinical workflows and should be used with strict procedural controls.

• KCNE4 Modulates Kv1.3 Blocker Pharmacology in Immune Cells

  2026-07-15

  This study reveals that the regulatory subunit KCNE4 alters the pharmacological properties of the Kv1.3 potassium channel in leukocytes. By demonstrating stoichiometry-dependent modulation of inhibition kinetics for both extracellular and intracellular Kv1.3 blockers, the research highlights the critical impact of channel complex composition on the efficacy and specificity of immunomodulatory strategies targeting Kv1.3.

16344 records 1/1090 page Next 12345 下5页 Last page